FDB Releases Patient-Specific Medication Decision Support Solution for Use in EHR Workflow

New targeted medication warnings address high risk clinical scenarios
including hyperkalemia, QT prolongation, opioid use, pharmacogenomics;
currently integrated in five hospital systems

ORLANDO, Fla.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Aim2Innovate?src=hash” target=”_blank”gt;#Aim2Innovatelt;/agt;–FDB (First Databank, Inc.), the leading provider of drug and medical
device knowledge that helps healthcare professionals make precise
decisions, announced the release of targeted medication decision support
that provides clinicians with more meaningful guidance at the most
appropriate time in the clinical workflow. FDB’s Targeted
Medication Warnings
leverage patient-specific, contextual clinical
information within the EHR to identify only the patients that manifest
the prescribing risk, so that resulting clinical guidance is more
meaningful and actionable. At present, five hospital systems have
integrated FDB’s Targeted Medication Warnings.

Medication decision support within healthcare IT systems has been
limited due to the lack of availability of broader patient information,
so knowledge bases and IT systems only considered the drug with limited
clinical context. Integrating patient record information presents
broader possibilities to be more specific and targeted and to take a
“patient first” approach. The benefits are significant because as
clinical decision support (CDS) incorporates more patient context, such
as lab values or clinical risk scores, it becomes more meaningful and
therefore more likely to be acted upon. This new, more targeted approach
is designed to improve the positive predictive value of alerts and
improve clinician efficiency over current CDS methods.

“We are thrilled with the reception that our newest approach to
medication decision support guidance has already received,” said Chuck
Tuchinda, MD, MBA, executive vice president, Hearst Health and
president, FDB. “Our goal in creating medication guidance that is
actionable, targeted and patient-specific, is to ensure it becomes more
meaningful and less likely to be overridden by clinicians, which
ultimately will lead to enhanced patient care and improved clinical
outcomes.”

The new targeted medication decision support from FDB focuses on
high-risk clinical scenarios such as hyperkalemia, QT prolongation,
opioid use, pharmacogenomics, and more. Patient-specific information,
such as lab values and clinical risk assessments, are pulled into the
guidance to provide actionable information at the right time in the
workflow. Traditional medication alerts that do not apply will be
demoted when Targeted Medication Warnings are implemented in the EHR, so
that end users are trading broader alerts for those that are more
targeted.

Currently available for Epic health system customers, FDB Targeted
Medication Warnings can also integrate with other technology solution
providers. To learn more about our patient-first approach to medication
decision support, please
visit us at HIMSS19
, and join us for a wine reception, Wednesday,
February 13, 2019, 4:30 – 6:00pm in booth #1921.

About First Databank

FDB is the leading provider of drug and medical device knowledge that
helps healthcare professionals make precise decisions. With thousands of
customers worldwide, FDB enables our information system developer
partners to deliver valuable, useful, and differentiated solutions. We
offer more than three decades of experience in transforming medical
knowledge into actionable, targeted, and effective solutions that help
improve patient safety, operational efficiency, and healthcare outcomes.
For a complete look at our solutions and services, please visit www.fdbhealth.com
or follow us on Twitter
and LinkedIn.

About Hearst Health

The Hearst Health network includes FDB
(First Databank), Zynx
Health
, MCG,
Homecare
Homebase
, MedHOK
and Hearst
Health Ventures
(www.hearsthealth.com).
Hearst also holds a minority interest in the precision medicine and
oncology analytics company M2Gen.
The mission of Hearst Health is to help guide the most important care
moments by delivering vital information into the hands of everyone who
touches a person’s health journey. Each year in the U.S., care guidance
from Hearst Health reaches 85 percent of discharged patients, 205
million insured individuals, 77 million home health visits and 3.2
billion dispensed prescriptions.

©2019 First Databank, Inc. Part of the Hearst Health network.
All trademarks mentioned herein are the properties of their respective
owners.

Contacts

Denise Apcar
First Databank (FDB)
650-872-4514
[email protected]

error: Content is protected !!